The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The multifaceted role of reactive oxygen species in tumorigenesis
Open accessAbstract
Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [77]
In the citing paper
“Elevated levels of intracellular ROS are known to be one of the reasons for genomic instability and, hence, carcinogenesis [29].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
In the citing paper
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
Citations
Cites
2 retracted
Items 201–257 of 257
Telomerase and drug resistance in cancer
Lipińska, N., Romaniuk-Drapała, A., Paszel-Jaworska, A., Totoń, E., Kopczyński, P., & Rubiś, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2573-2 · Cited by 101
Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis
Park, S., Oh, J., Kim, M., & Jin, E. (2018) · Animal Cells and Systems · doi:10.1080/19768354.2018.1512521 · Cited by 100
A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
Bollong, M. J., Yun, H., Sherwood, L., Woods, A. K., Lairson, L. L., & Schultz, P. G. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00448 · Cited by 98
Glasauer, A., & Chandel, N. S. (2013) · Current Biology · doi:10.1016/j.cub.2012.12.011 · Cited by 95
McLean, L. S., Soto, U., Agama, K., Francis, J., Jimenez, R. M., Pommier, Y. G., Sowers, L. C., & Brantley, E. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.23244 · Cited by 94
Li, J., Lan, T., Zhang, C., Zeng, C., Hou, J., Yang, Z., Zhang, M., Liu, J., & Liu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.2671 · Cited by 93
Kasukabe, T., Honma, Y., Okabe‐Kado, J., Higuchi, Y., Kato, N., & Kumakura, S. (2016) · Oncology Reports · doi:10.3892/or.2016.4867 · Cited by 93
Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells
Chien, W., Ding, L., Sun, Q., Fernández, L. T., Tan, S. Z., Xiao, J.-F., Lim, S. L., Garg, M., Lee, K. L., Kitajima, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2051 · Cited by 89
Self-citationGiambra, V., Jenkins, C. R., Wang, H., Lam, S. H. L., Shevchuk, O. O., Nemirovsky, O., Wai, C., Gusscott, S., Chiang, M. Y., Aster, J. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2960 · Cited by 87
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
Sun, Q.-Y., Ding, L.-W., Tan, K. T., Chien, W., Mayakonda, A., Lin, D.-C., Loh, X.-Y., Xiao, J.-F., Meggendorfer, M., Alpermann, T., et al. (2016) · Leukemia · doi:10.1038/leu.2016.160 · Cited by 87
Self-citationLin, X., Zheng, W., Liu, J., Zhang, Y., Qin, H., Wu, H., Xue, B., Lu, Y., & Shen, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4617 · Cited by 85
A powerful cell-protection system prevents cell death by ferroptosis
Stockwell, B. R. (2019) · Nature · doi:10.1038/d41586-019-03145-8 · Cited by 85
亜ヒ酸ナトリウムは,ヒト乳癌MCF‐7細胞においてROS発生,DNA酸化損傷,HO‐1とc‐Myc蛋白質,NF‐κB活性化および細胞増殖を誘導する
Ruben, R.-R., Lizbeth, L.-C., Alfonso, D. R.-P., de Andréa, & Mariano, E. C. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · Cited by 83
Grant, W. B. (2019) · Anticancer Research · doi:10.21873/anticanres.13977 · Cited by 81
Sobhakumari, A., Love-Homan, L., Fletcher, E. V. M., Martin, S. M., Parsons, A. D., Spitz, D. R., Knudson, C. M., & Simons, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048175 · Cited by 80
Quantitative assessment of telomerase components in cancer cell lines
Akıncılar, S. C., Low, K. C., Liu, C. Y., Yan, T. D., Oji, A., Ikawa, M., Li, S., & Tergaonkar, V. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.035 · Cited by 80
STAT5 triggersBCR-ABL1mutation by mediating ROS production in chronic myeloid leukaemia
Warsch, W., Grundschober, E., Berger, A., Gille, L., Cerny‐Reiterer, S., Tigan, A.-S., Hoelbl‐Kovacic, A., Valent, P., Moriggl, R., & Sexl, V. (2012) · Oncotarget · doi:10.18632/oncotarget.806 · Cited by 79
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells
Valenzuela, M., Glorieux, C., Stockis, J., Sid, B., Sandoval, J. M., Felipe, K. B., Kviecinski, M. R., Verrax, J., & Calderón, P. B. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.380 · Cited by 75
Kim, C., Cho, S. K., Kim, K.-D., Nam, D., Chung, W., Jang, H.-J., Lee, S., Shim, B. S., Sethi, G., & Ahn, K. S. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0957-9 · Cited by 73
Self-citationLAMC2 as a therapeutic target for cancers
Garg, M., Braunstein, G. D., & Koeffler, H. P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.934814 · Cited by 73
Self-citationKim, M., Cui, F., & Kim, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3625 · Cited by 72
Kim, S., Kim, C., Bae, H., Lee, J. H., Baek, S. H., Nam, D., Chung, W., Shim, B. S., Lee, S., Kim, S., et al. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22184 · Cited by 70
Self-citationLewis-Wambi, J. S., Kim, H. R., Wambi, C. O., Patel, R. R., Pyle, J. R., Klein–Szanto, A. J., & Jordan, V. C. (2008) · Breast Cancer Research · doi:10.1186/bcr2208 · Cited by 67
Woolley, J. F., Naughton, R., Stanicka, J., Gough, D. R., Bhatt, L., Dickinson, B. C., Chang, C. J., & Cotter, T. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034050 · Cited by 64
Wei, J., Zhang, M., & Zhou, J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.002 · Cited by 63
Chen, J., Da, W.-M., Zhang, D., Liu, Q., & Kang, J. (2005) · PubMed · Cited by 63
H2O2 mediates oxidative stress-induced epidermal growth factor receptor phosphorylation
Meves, A., Stock, S. N., Beyerle, A., Pittelkow, M. R., & Péus, D. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00359-9 · Cited by 62
A candidate for lung cancer treatment: arsenic trioxide
Huang, W., & Zeng, Y. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02054-6 · Cited by 61
Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Ayyanathan, K., Kesaraju, S., Dawson-Scully, K. D., & Weissbach, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039949 · Cited by 60
Ko, E., Seo, H., & Jung, G. (2017) · Hepatology · doi:10.1002/hep.29604 · Cited by 60
Engineering anti-cancer nanovaccine based on antigen cross-presentation
Warrier, V. U., Makandar, A. I., Garg, M., Sethi, G., Kant, R., Pal, J. K., Yuba, E., & Gupta, R. K. (2019) · Bioscience Reports · doi:10.1042/bsr20193220 · Cited by 60
Self-citationThe prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis
Almeida, M., Soares, M., Ramalhinho, A. C., Fonseca-Moutinho, J. A., Breitenfeld, L., & Pereira, L. C. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05494-4 · Cited by 57
Habermann, K., Grünewald, L. D., van Wijk, S. J. L., & Fulda, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.412 · Cited by 56
Lee, J. H., Kim, C., Lee, S., Yang, W. M., Um, J., Sethi, G., & Ahn, K. S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.01.002 · Cited by 56
Self-citationCai, Y.-J., Lu, J., Zhu, H., Xie, H., Huang, M., Lin, L., Zhang, X., & Ding, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.017 · Cited by 54
Cysteine-based regulation of redox-sensitive Ras small GTPases
Messina, S., Simone, G. D., & Ascenzi, P. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101282 · Cited by 52
Hedley, D. W., Pintilie, M., Woo, J. M. P., Nicklee, T., Morrison, A. J., Birle, D. C., Fyles, A., Milosevic, M., & Hill, R. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63145-8 · Cited by 50
Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model
Klose, J., Trefz, S., Wagner, T., Steffen, L., Charrier, A. P., Radhakrishnan, P., Volz, C., Schmidt, T., Ulrich, A. B., Dieter, S. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211916 · Cited by 47
Su, W.-P., Lo, Y.-C., Yan, J., Liao, I., Tsai, P.-J., Wang, H., Yeh, H.-H., Lin, C., Chen, H. H. W., Lai, W., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs253 · Cited by 45
Chien, W., Sudo, M., Ding, L., Sun, Q., Wuensche, P., Lee, K. L., Hattori, N., Garg, M., Xu, L., Zheng, Y., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25138 · Cited by 38
Self-citationPatel, D., Kharkar, P. S., Gandhi, N. S., Kaur, E., Dutt, S., & Nandave, M. (2019) · Drug Development Research · doi:10.1002/ddr.21557 · Cited by 38
Chen, Q., Jiang, C., Zhang, J., & Ding, J. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200101000-00007 · Cited by 37
Gahr, S., Ocker, M., Ganslmayer, M., Zopf, S., Okamoto, K., Hartl, A., Leitner, S., Hahn, E. G., & Herold, C. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.567 · Cited by 31
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30
Benzyl Isothiocyanate: Double Trouble for Breast Cancer Cells
Rao, C. V. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0242 · Cited by 29
Pharmacology of a mimetic of glutathione disulfide, NOV-002
Townsend, D. M., & Tew, K. D. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.08.019 · Cited by 27
LNK (SH2B3): paradoxical effects in ovarian cancer
Ding, L.-W., Sun, Q.-Y., Lin, D.-C., Chien, W., Hattori, N., Dong, X.-M., Gery, S., Garg, M., Doan, N., SAID, J. W., et al. (2014) · Oncogene · doi:10.1038/onc.2014.34 · Cited by 26
Self-citationGarg, M., Okamoto, R., Nagata, Y., Kanojia, D., Venkatesan, S. S., Anand, M. T., Braunstein, G. D., SAID, J. W., Doan, N., Ho, Q. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2359 · Cited by 26
Self-citationElevation of cysteine consumption in tamoxifen-resistant MCF-7 cells
Ryu, C. S., Kwak, H. C., Lee, J.-Y., Oh, S. J., Phương, N. T. T., Kang, K. W., & Kim, S. K. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.021 · Cited by 25
Wang, H., Sim, M., Loke, W. K., Chinnathambi, A., Alharbi, S. A., Tang, F. R., & Sethi, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00352 · Cited by 24
Self-citationDietary vitamin A intake and the risk of ovarian cancer: a meta-analysis
Wang, Q., & He, C. (2020) · Bioscience Reports · doi:10.1042/bsr20193979 · Cited by 24
Immunogenicity and contraceptive potential of recombinant human sperm associated antigen (SPAG9)
Jagadish, N., Rana, R., Mishra, D., Garg, M., Chaurasiya, D., Hasegawa, A., Koyama, K., & Suri, A. (2005) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.06.004 · Cited by 19
Self-citationA systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics
Sidhanth, C., Manasa, P., Krishnapriya, S., Sneha, S., Bindhya, S., Nagare, R. P., Garg, M., & Ganesan, T. S. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0020 · Cited by 17
Self-citationRana, R., Jagadish, N., Garg, M., Mishra, D., Dahiya, N., Chaurasiya, D., & Suri, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.168 · Cited by 12
Self-citationDiagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD
Chien, W., Sun, Q.-Y., Ding, L.-W., Mayakonda, A., Takao, S., Liu, L., Lim, S. L., Tan, K. T., Garg, M., Varela, A. D. S. M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.343 · Cited by 10
Self-citationRedox Dichotomy in Cell Fate Decision: Evasive Mechanism or Achilles Heel?
Pervaiz, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7586 · Cited by 10
Cell signaling and fate through the redox lens
Pervaiz, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101298 · Cited by 4
Cited by
Sorted by citations
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, Y., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,078
“It has been demonstrated by Lin X et al. that ROS may stimulate an invasive phenotype in TAMs derived from melanoma through the secretion of TNFα.343 Researchers have found several mitochondrial genes highly expressed in TAMs derived from melanomas, indicating ROS is the major cause of oxidative stress within TAMs.334…”
BackgroundInfluentialEmerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 582
Self-citationAfzal, S., Manap, A. S. A., Attiq, A., Albokhadaim, I. F., Kandeel, M. K., & Alhojaily, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 482
Weaver, K., & Skouta, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040891 · Cited by 288
“Recent studies showed that oxidative injuries were involved in neurodegeneration such as Alzheimer’s and Parkinson’s disease [53,54], cancer [55,56], diabetes [57], and cardiovascular diseases [58,59].”
BackgroundGuan, Z., Chen, J., Li, X., & Dong, N. (2020) · Bioscience Reports · doi:10.1042/bsr20201807 · Cited by 235
Metadata
- Authors
- Kirtonia, A., Sethi, G., & Garg, M.
- Affiliations
- Amity University (IN)
- National University of Singapore (SG)
- Corresponding author
- Sethi, Gautam
- Garg, Manoj
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2020-05-01
- Volume
- 77
- Issue
- 22
- Pages
- 4459-4483
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105050
- OpenAlex
- W3022746266
- Cited by
- 452
- References
- 257
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 90 · 2023: 72 · 2022: 106 · 2021: 80 · 2020: 26
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- reactive oxygen species, carcinogenesis, redox homeostasis, oxidative stress, metastasis, angiogenesis, oncogenic signaling, DNA mutations, tumor microenvironment, cancer stem cells, drug resistance, anticancer agents, immunotherapy, radiotherapy, chemotherapy
- MeSH terms
- Animals, Humans, Neoplasm Recurrence, Local, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
